Acute lymphoblastic leukaemia (ALL) diagnosis and treatment statistics

'14-day / Two-week wait'

England meets the standard for their country on the percentage of patients first seen by a specialist within two weeks of urgent GP referral for suspected cancer.[1]

'Two-week wait' supports early diagnosis as spotting cancer early is important for improving survival, so it is important that patients with potential cancer symptoms are referred promptly. 

'31-day wait'

Wales meets the standard for their country on the percentage of patients that receive their first cancer treatment within 31 days of a decision to treat, while England does not meet the standard for their country.[1,2]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

Cancer waiting times coding and standards are different in each country and so comparisons should not be made between countries, only each country against their own measures.

Acute Leukaemia, Waiting Times, UK countries, 2014-15

    England Wales Scotland Northern Ireland
'14-day wait': seen by specialist following referral Performance 94.1%      
Standard 93%      
Performance against standard Meets standard      
'31-day wait': receipt of first treatment following decision to treat Performance 78.3% 100%    
Standard 96% 98%    
Performance against standard Does not meet standard Meets Standard    

Data not available for '14-day wait' in Wales, Scotland or NI.
Data not available for '31-day wait' in Scotland or NI.
Data too small for '62-day wait' for Wales and not available for England, Scotland or NI.
Last reviewed:

The National Cancer Patient Experience Survey monitors patients’ self-reported satisfaction with each step of the cancer pathway in England, providing information to drive improvements in cancer care.[1] The survey has been conducted annually since 2010.

Overall, most cancer patients in England report positive experiences of cancer care. However patient experience varies along the cancer pathway, and by gender, ethnicity, age, deprivation, and cancer type. Satisfaction scores tend to be higher for experiences with Clinical Nurse Specialists and other hospital staff, and lower for experiences with GPs and general practice staff. Patients who report more positive experiences of cancer diagnosis and treatment tend to be male, white, older, and less deprived.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.


You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online


We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 2 out of 5 based on 11 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page